StockComparison Logo
vs

SCL vs MLTX

Comparison between Stepan Company (SCL, Company) and MoonLake Immunotherapeutics - Class A (MLTX, Company).

SCL is from the Basic Materials sector, while MLTX is from the Healthcare sector.

5-Year PerformanceMLTX has outperformed SCL, delivering a return of +14.1% compared to -11.5%

SCL vs MLTX - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
SCL
$1.35B
Winner
MLTX
$1.35B
Max Drawdown
Winner
SCL
69.33%
MLTX
90.22%
Sharpe Ratio
SCL
0.19
Winner
MLTX
0.52
5Y Beta
SCL
0.98
Winner
MLTX
0.95
Industry
SCL
Specialty Chemicals
MLTX
Biotechnology
P/E Ratio
SCL
2590.93
Winner
MLTX
-5.29
Forward P/E
SCL
22.62
MLTX
N/A
PEG Ratio
SCL
1.75
Winner
MLTX
-0.03
Dividend Yield
SCL
2.66%
MLTX
N/A
5Y Dividends CAGR
SCL
5.70%
MLTX
N/A
5Y EPS CAGR
SCL
-65.69%
MLTX
N/A
Debt to Equity
SCL
54.63%
Winner
MLTX
38.98%
Free Cash Flow Yield
Winner
SCL
2.76%
MLTX
-16.60%
P/S Ratio
SCL
0.57
MLTX
N/A
P/B Ratio
Winner
SCL
1.12
MLTX
6.60

SCL vs MLTX - Historical Returns

Returns include dividend reinvestment.

1M
Winner
SCL
+9.19%
MLTX
-8.77%
3M
SCL
+12.10%
Winner
MLTX
+14.35%
6M
SCL
+4.50%
Winner
MLTX
+22.07%
1Y
Winner
SCL
+2.87%
MLTX
-65.27%
5Y(CAGR)
SCL
-11.53%
Winner
MLTX
+14.13%
10Y(CAGR)
SCL
+0.36%
MLTX
N/A
Max(CAGR)
SCL
+8.36%
Winner
MLTX
+11.24%

SCL vs MLTX - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearSCLMLTX
2026+24.02%+62.01%
2025-22.75%-75.40%
2024-29.48%-9.07%
2023-7.75%+447.76%
2022-12.77%+5.85%
2021+3.69%-8.76%
2020+15.69%+8.39%
2019+39.84%N/A
2018-6.20%N/A
2017-1.14%N/A
2016+73.31%N/A
2015+26.22%N/A
2014-37.62%N/A
2013+18.33%N/A
2012+41.78%N/A
2011+5.32%N/A
2010+15.49%N/A
2009+41.39%N/A
2008+53.01%N/A
2007+7.15%N/A
2006+18.77%N/A
2005+15.55%N/A
2004-2.23%N/A
2003+5.01%N/A
2002+2.45%N/A
2001+11.91%N/A
2000+5.75%N/A
1999-1.43%N/A

SCL vs MLTX Drawdown Comparison

The maximum drawdown for SCL was -66.77%, occurring on Nov 4, 2025. This drawdown has not yet recovered.

The maximum drawdown for MLTX was -90.22%, occurring on Sep 29, 2025. This drawdown has not yet recovered.

The current SCL drawdown is -53.67%. The current MLTX drawdown is -69.68%.

RankSCLMLTX
#1-66.77%
May 6, 2021 - Nov 4, 2025
-90.22%
Feb 12, 2024 - Sep 29, 2025
#2-60.98%
Aug 14, 2008 - Sep 10, 2009
-64.60%
Apr 5, 2022 - Feb 7, 2023
#3-43.86%
Dec 23, 2013 - Jul 21, 2016
-41.80%
Oct 5, 2023 - Dec 27, 2023
#4-32.15%
Jan 13, 2020 - Jul 23, 2020
-25.65%
Feb 18, 2021 - Apr 5, 2022
#5-31.96%
Jul 13, 2001 - Mar 8, 2002
-19.79%
Mar 8, 2023 - Apr 24, 2023
#6-30.85%
Apr 29, 2010 - Jul 27, 2011
-18.38%
Jul 28, 2023 - Oct 5, 2023
#7-30.20%
Jan 13, 2010 - Apr 20, 2010
-15.06%
Dec 27, 2023 - Feb 9, 2024
#8-25.43%
Jul 5, 2000 - Jan 18, 2001
-14.12%
Apr 24, 2023 - May 4, 2023
#9-25.18%
Aug 7, 2002 - Sep 6, 2005
-12.27%
Jun 9, 2023 - Jun 26, 2023
#10-24.63%
Jul 25, 2017 - Feb 13, 2019
-7.95%
Jul 19, 2023 - Jul 26, 2023
#11-21.41%
Jul 10, 2006 - Jul 19, 2007
-7.48%
Jul 5, 2023 - Jul 14, 2023
#12-18.09%
Dec 9, 2016 - Apr 25, 2017
-5.83%
Oct 22, 2020 - Dec 1, 2020
#13-18.01%
Mar 15, 2013 - Dec 6, 2013
-5.45%
May 10, 2023 - May 25, 2023
#14-17.97%
Dec 24, 2007 - Feb 27, 2008
-5.45%
Dec 31, 2020 - Jan 8, 2021
#15-17.96%
Jul 28, 2011 - Oct 27, 2011
-4.78%
Jan 8, 2021 - Feb 11, 2021

Correlation

Correlation between SCL and MLTX is -0.41 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.41
-101

Select Stocks to Compare